| Indicators of responsiveness to immune checkpoint inhibitors BD Shields, F Mahmoud, EM Taylor, SD Byrum, D Sengupta, B Koss, ... Scientific reports 7 (1), 807, 2017 | 89 | 2017 |
| Loss of E-cadherin inhibits CD103 antitumor activity and reduces checkpoint blockade responsiveness in melanoma BD Shields, B Koss, EM Taylor, AJ Storey, KL West, SD Byrum, ... Cancer research 79 (6), 1113-1123, 2019 | 58 | 2019 |
| Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack F Mahmoud, B Shields, I Makhoul, N Avaritt, HK Wong, LF Hutchins, ... Cancer biology & therapy 18 (7), 451-469, 2017 | 56 | 2017 |
| Role of EZH2 histone methyltrasferase in melanoma progression and metastasis F Mahmoud, B Shields, I Makhoul, LF Hutchins, SC Shalin, AJ Tackett Cancer biology & therapy 17 (6), 579-591, 2016 | 51 | 2016 |
| Quantitative histone mass spectrometry identifies elevated histone H3 lysine 27 (Lys27) trimethylation in melanoma D Sengupta, SD Byrum, NL Avaritt, L Davis, B Shields, F Mahmoud, ... Molecular & Cellular Proteomics 15 (3), 765-775, 2016 | 32 | 2016 |
| Epigenetic Control of Cdkn2a.Arf Protects Tumor-Infiltrating Lymphocytes from Metabolic Exhaustion B Koss, BD Shields, EM Taylor, AJ Storey, SD Byrum, AJ Gies, ... Cancer research 80 (21), 4707-4719, 2020 | 23 | 2020 |
| Validity and reliability of the Patient-Reported Arthralgia Inventory: validation of a newly-developed survey instrument to measure arthralgia LD Castel, KA Wallston, BR Saville, JAR Alvarez, BD Shields, ID Feurer, ... Patient Related Outcome Measures, 205-214, 2015 | 12 | 2015 |
| Do checkpoint inhibitors rely on gut microbiota to fight cancer? B Firwana, N Avaritt, B Shields, R Ravilla, I Makhoul, L Hutchins, ... Journal of Oncology Pharmacy Practice 24 (6), 468-472, 2018 | 4 | 2018 |
| E-cadherin enhances immune control of metastatic melanoma BD Shields, B Koss, F Mahmoud, SD Byrum, AJ Tackett Cancer Research 78 (13_Supplement), 2037-2037, 2018 | 3 | 2018 |
| Proteomics and melanoma: a current perspective BD Shields, AJ Tackett, SC Shalin Global dermatology 3 (4), 366, 2016 | 3 | 2016 |
| Microscopes and Mass Spectrometers B Shields, SC Shalin, AJ Tackett Journal of proteomics & bioinformatics 9 (Suppl 10), 2016 | 1 | 2016 |
| Methods for predicting responsiveness of a cancer to an immunotherapeutic agent and methods of treating cancer B Shields, A Tackett, S Byrum, F Mahmoud, S Shalin US Patent 11,561,224, 2023 | | 2023 |
| Epigenetic control of tumor-infiltrating lymphocyte metabolic-exhaustion B Koss, BD Shields, EM Taylor, AJ Storey, SD Byrum, AJ Gies, ... Cancer Research 80 (16_Supplement), 1029-1029, 2020 | | 2020 |
| Abstract LB-182: Combination of sulforaphane and 5-aza-2′-deoxycytidine slows the growth and upregulates the chemoattractant CCL5 in metastatic melanoma TC Chiang, B Koss, AJ Storey, J Zabaleta, SR Choudhury, BD Shields, ... Cancer Research 80 (16_Supplement), LB-182-LB-182, 2020 | | 2020 |
| Combination of sulforaphane and 5-aza-2'-deoxycytidine slows the growth and upregulates the chemoattractant CCL5 in metastatic melanoma TC Chiang, B Koss, AJ Storey, J Zabaleta, SR Choudhury, BD Shields, ... CANCER RESEARCH 80 (16), 2020 | | 2020 |
| Abstract LB-206: Indicators of responsiveness to immune checkpoint inhibitors BD Shields, F Mahmoud, EM Taylor, SD Byrum, D Sengupta, B Koss, ... Cancer Research 77 (13_Supplement), LB-206-LB-206, 2017 | | 2017 |
| Epigenetic Control of Cdkn2a. Arf Protects Tumor-Infiltrating Lymphocytes from Metabolic B Koss, BD Shields, EM Taylor, AJ Storey, SD Byrum, AJ Gies, ... | | |
